Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats
- Authors:
- Published online on: January 1, 2006 https://doi.org/10.3892/ijmm.17.1.15
- Pages: 15-20
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
The effect of β-cryptoxanthin, a kind of carotenoid, on ovariectomy-induced bone loss was investigated. β-cryptoxanthin was isolated from Satsuma mandarin (Citrus unshu. MARC). β-cryptoxanthin (5 or 10 µg/100 g body weight) was orally administered once daily for 3 months to ovariectomized (OVX) rats. OVX induced a significant increase in body weight and a significant decrease in serum calcium and inorganic phosphorus concentrations as compared with those of sham-operated (control) rats. These alterations induced by OVX were significantly prevented by the administration of β-cryptoxanthin (5 or 10 µg/100 g). The analysis using a peripheral quantitative computed tomography (pQCT) showed that OVX induced a significant decrease in mineral content and mineral density in the femoral-diaphyseal and -metaphyseal tissues and polar strength strain index in the metaphyseal tissues. These decreases were significantly prevented by the administration of β-cryptoxanthin (5 or 10 µg/100 g). Moreover, OVX induced a significant decrease in calcium content and alkaline phosphatase activity in the femoral-diaphyseal and -metaphyseal tissues and deoxyribonucleic acid (DNA) content in the metaphyseal tissues. These decreases were significantly prevented by the administration of β-cryptoxanthin (5 or 10 µg/100 g). This study demonstrates that β-cryptoxanthin has a preventive effect on OVX-induced bone loss in vivo.